Burcon Nutrascience Corporation
BU.TO
TSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | 137.40K | -- | 0.00 | 118.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 137.40K | -- | 0.00 | 118.80K |
| Cost of Revenue | -- | -- | -- | -621.00K | -- |
| Gross Profit | -- | 137.40K | -- | 621.00K | 118.80K |
| SG&A Expenses | 666.60K | 620.50K | 644.20K | 713.10K | 728.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.39M | 1.28M | 1.32M | 1.27M | 1.43M |
| Operating Income | -1.39M | -1.14M | -1.32M | -1.27M | -1.31M |
| Income Before Tax | -1.49M | -1.07M | -1.42M | -1.40M | -12.01M |
| Income Tax Expenses | -- | -- | -- | -42.40K | -- |
| Earnings from Continuing Operations | -1.49M | -1.07M | -1.42M | -1.35M | -12.01M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.49M | -1.07M | -1.42M | -1.35M | -12.01M |
| EBIT | -1.39M | -1.14M | -1.32M | -1.27M | -1.31M |
| EBITDA | -1.36M | -1.10M | -1.28M | -1.22M | -1.27M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.11 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | 0.01 | -0.04 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.11 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | 0.01 | -0.04 |
| Average Basic Shares Outstanding | 121.69M | 121.67M | 115.99M | 108.73M | 108.73M |
| Average Diluted Shares Outstanding | 121.69M | 121.67M | 115.99M | 108.73M | 108.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
